货币 / ALC
ALC: Alcon Inc
86.91
USD
0.70
(0.80%)
今日ALC汇率已更改-0.80%。当日,交易品种以低点85.52和高点87.63进行交易。
关注Alcon Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ALC新闻
- Seeking Alpha Parnassus Mid Cap Growth Fund Q2 2025 Commentary
- Seeking Alpha Parnassus Mid Cap Fund Q2 2025 Commentary
- Seeking Alpha Harding Loevner Global Equity Q2 2025 Report
- Investing Stifel reiterates Buy rating on Alcon stock, maintains $100 price target
- Investing RxSight stock rating downgraded to Neutral by BTIG amid sales challenges
- Investing Alcon’s vitreoretinal-cataract system receives Health Canada approval
- Investing Alcon to acquire LumiThera and its dry AMD light therapy device
- Investing DP World subsidiary to acquire 51% stake in NovaAlgoma cement assets
- Investing Stifel reiterates Buy rating on Alcon stock amid IOL market dynamics
- Investing UBS downgrades Galderma to “neutral” on valuation concerns, softer aesthetics
- Investing Alcon Canada Earns Global Recognition as a Top Employer
- Investing # Alcon’s new eye lens reduces light scatter for cataract patients
- Seeking Alpha Impax Global Social Leaders Fund Q1 2025 Commentary (Mutual Fund:IGSLX)
- Investing UBS identifies stock winners amid structural growth tailwinds
- Seeking Alpha Alcon’s Tryptyr Adds Growth, But Valuation Keeps Shares On 'Hold' (NYSE:ALC)
- Investing Citi more constructive on EU MedTech: Upgrades Demant; Alcon top pick
- Seeking Alpha Thornburg Better World International Fund Q1 2025 Commentary
- Investing BofA Securities lowers Alcon stock price target after Q1 results
- Investing Analysts assess the potential impact of Trump’s surprise 50% steel tariffs
- Investing Citi maintains Buy on Alcon, price target CHF99 after FDA nod
- Seeking Alpha Madison Large Cap Fund Q1 2025 Investment Strategy Letter
- Benzinga Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
- Investing BTIG maintains Alcon $99 target, upbeat on TRYPTYR launch
- Investing FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment
日范围
85.52
87.63
年范围
80.48
101.10
- 前一天收盘价
- 85.94
- 开盘价
- 87.61
- 卖价
- 86.91
- 买价
- 87.21
- 最低价
- 85.52
- 最高价
- 87.63
- 交易量
- 5.283 K
- 日变化
- -0.80%
- 月变化
- -0.97%
- 6个月变化
- -4.14%
- 年变化
- -6.97%
17 七月, 星期四
12:30
USD
- 实际值
- 预测值
- 0.1%
- 前值
- -0.9%
12:30
USD
- 实际值
- 预测值
- 0.0%
- 前值
- -0.3%
12:30
USD
- 实际值
- 预测值
- 0.1%
- 前值
- 0.4%
12:30
USD
- 实际值
- 预测值
- -0.1%
- 前值
- -0.1%
12:30
USD
- 实际值
- 预测值
- 4.2%
- 前值
- 3.3%
12:30
USD
- 实际值
- 预测值
- -0.1%
- 前值
- 0.0%
12:30
USD
- 实际值
- 预测值
- 1.1%
- 前值
- 0.2%
12:30
USD
- 实际值
- 预测值
- 0.1%
- 前值
- -0.9%
12:30
USD
- 实际值
- 预测值
- 0.7%
- 前值
- 1.7%
12:30
USD
- 实际值
- 预测值
- 0.2%
- 前值
- 0.2%
12:30
USD
- 实际值
- 预测值
- 3.4
- 前值
- -4.0
12:30
USD
- 实际值
- 预测值
- -4.1
- 前值
- -9.8
12:30
USD
- 实际值
- 预测值
- 25.2
- 前值
- 18.3
12:30
USD
- 实际值
- 预测值
- 52.9
- 前值
- 41.4
12:30
USD
- 实际值
- 预测值
- 10.7
- 前值
- 2.3
12:30
USD
- 实际值
- 预测值
- 18.7
- 前值
- 14.5
12:30
USD
- 实际值
- 预测值
- 218 K
- 前值
- 227 K
12:30
USD
- 实际值
- 预测值
- 1.958 M
- 前值
- 1.965 M
12:30
USD
- 实际值
- 预测值
- 232.450 K
- 前值
- 235.500 K
14:00
USD
- 实际值
- 预测值
- 0.3%
- 前值
- 0.0%
14:00
USD
- 实际值
- 预测值
- -0.1%
- 前值
- -0.1%
14:00
USD
- 实际值
- 预测值
- 前值
- 0.2%
14:00
USD
- 实际值
- 预测值
- 30
- 前值
- 32
14:30
USD
- 实际值
- 预测值
- 54 B
- 前值
- 53 B
15:30
USD
- 实际值
- 预测值
- 前值
- 4.235%
15:30
USD
- 实际值
- 预测值
- 前值
- 4.275%
17:30
USD
- 实际值
- 预测值
- 前值
20:00
USD
- 实际值
- 预测值
- $63.1 B
- 前值
- $-7.8 B
20:00
USD
- 实际值
- 预测值
- $42.2 B
- 前值
- $-7.8 B
20:00
USD
- 实际值
- 预测值
- $147.2 B
- 前值
- $-14.2 B
20:00
USD
- 实际值
- 预测值
- $-0.8 B
- 前值
- $-40.8 B
22:30
USD
- 实际值
- 预测值
- 前值